Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): Is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA?

Therapeutic Apheresis

Volumn 2, Issue 1, 1998, Pages 65-70

  Kanemitsu, Seiyu ^a   Takekoshi, Noboru ^a   Matsui, Shinobu ^a   Tsugawa, Hiroichi ^a   Ohkubo, Shinji ^a   Kitayama, Michihiko ^a   Matsuda, Takeshi ^a   Senma, Junji ^a   Masuyama, Kazuhiko ^a   Yamagata, Toshirou ^a   Murakami, Eiji ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Lipoprotein(a); Low density lipoprotein apheresis; Restenosis after percutaneous transluminal coronary angioplasty

Indexed keywords

LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0031861478     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1998.tb00075.x     Document Type: Article

References (28)

1. Leimgruber PP, Roubin GS, Hollman J, Cotsonis GA, Meier B, Douglas JS, King SB, Gruentzig AR. Restenosis after successful coronary angioplasty in patients with single vessel disease. Circulation 1986;73:710-7.
2. Levine S, Ewels GJ, Rosing DR, Kent KM. Coronary angioplasty: Clinical and angiographic follow up. Am J Cardiol 1985;55:673-6.
3. Olmes DR, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, Faxon DP, Gruentzig AR, Kelsey SF, Detre KM, Van Raden MJ, Mock MB. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from PTCA registry of the National Heart, Lung and Blood Institute. Am J Cardiol 1984;53:77C-81C.
4. Mata LA, Bosch X, David PR, Rapold HJ, Corcos T, Bourassa MG. Clinical and angiographie assessment 6 months after double vessel percutaneous coronary angioplasty. J Am Coll Cardiol 1985;6:1239-44.
5. Jang GC, Block PC, Cowley MJ, Gruentzig AR, Dorros G, Holmes DR, Kent KM, Leatherman LL, Myler RK, Sjolander SME, Stertzer SH, Vetrovec GW, Willis WH, Williams DO. Relative costs of coronary angioplasty and bypass surgery in a one vessel disease model. Am J Cardiol 1984;53:52C-5C.
6. Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB III. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989;117:777-82.
7. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatoni VA, Henderson M, Bonan R, David PR. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988;318:1714-9.
8. Thornton MA, Gruentzig AR, Hollman J, King SB III, Douglas JS. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: A randomized study. Circulation 1984;69:721-7.
9. Corcos T, David PR, Guiteras Val P, Renkin J, Dangoisse V, Rapold HG. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1985;109:926-31.
10. Serruys PW, Rutsch W, Heyndrickx GR, Danchin N, Mast G, Wijns W, Rensing BJ, Vos J, Stibbe J, CARPORT Study Group. Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2 receptor blockade: A randomized, double blind, placebo-controlled trial. Circulation 1991;84:1568-80.
11. Hermans WRM, Rensing BJ, Strauss BH, Serruys PW. Prevention of restenosis after percutaneous transluminal coronary angioplasty (PTCA): The search for a magic bullet. Am Heart J 1991;122:171-87.
12. Dahlen GH, Guyton Jr, Sttar MK, Farner JA, Gotto AM Jr. Association of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74:758-65.
13. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986;256:2540-44.
14. Oshima S, Uchida K, Yasu T, Uno K, Nonogi H, Haze K. Transient increase of plasma lipoprotein(a) in patients with unstable angina pectoris. Arterioscler Thromb 1991;11:1772-7.
15. Hoff HF, Beck GJ, Skibinski CI, Jurgens G, O'Neill J, Kramer J, Lytle B. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988;77:1238-44.
16. James AH, Bryan CD, Hisham B, John SD, Spencer BK III, Nicholas JL, Gary SR, Demetrios SS. Usefulness of serum lipoprotein(a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1992;69: 736-9.
17. Yamamoto H, Imazu M, Yamabe T, Ueda H, Hattori Y, Yamakido M. Risk factors for restenosis after percutaneous transluminal coronary angioplasty: Role of lipoprotein(a). Am Heart J 1995;130:68-73.
18. Mabuchi H, Michishita I, Takeda M, Fujita H, Koizumi J, Takeda R, Takada S, Oonishi M. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 1987;68:19-25.
19. U.S. Department of Health, Education, and Welfare. National Institutes of Health. Lipid Research Clinics Program. Manual of Laboratory operation, Vol. 1. Lipid and lipoprotein analysis. Washington, D.C.: U.S. Government Printing Office, DHEW publication no. (NIH) 75-628, 1974.
20. Friedenwald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-508.
21. Ventrex Laboratories, Inc., Instructional Manual. Ventrex RIA for apolipoprotein A-I and B. Portland, ME: Ventrex, 1988.
22. Brandstrom A, Johnson O, Dahlen G, Ranby M. Lp(a) levels in a healthy population measured by a new enzyme linked immuno sorbent assay (abstract). Thromb Haemostasis 1989; 62:573.
23. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding and plasminogen activation. Arteriosclerosis 1990;10:240-5.
24. Morimoto SI, Mizuno Y, Hiramitsu S, Yamada K, Kubo N, Nomura M. Restenosis after percutaneous transluminal coronary angioplasty-a histopathological study using autopsied hearts. Jpn Circ J 1990;54:43-56.
25. Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 1974; 71:1207-10.
26. Myler RK, Topol EJ, Shaw RE, Stertzer SH, Clark DA, Fishman J, Murphy MC. Multiple-vessel coronary angioplasty: Classification results and patterns of restenosis in 494 consecutive patients. Catheterization Cardiovasc Diagn 1987;13: 1-15.
27. Rakesh S, Alan RM, Gerardo V, Vidya SB. Prevention of restenosis by lovastatin after successful coronary angioplasty. Am Heart J 1991;121:1600.
28. Okamura K, Toujyo O, Arai H, Saitou S, Kubori S, Kitaoka T. Treatment of familial hyperlipidemia complicated by ischemic heart disease-focus on LDL apheresis-. Treatment 1988; 70:2277-81.